They conclude, the loss of dopamine neurons in PD is likely to contribute to dysfunctional glucose metabolism. They also note the growing amount of literature arguing mitochondrial dysfunction is common in PD and is causing metabolic dysfunction
Weight loss follows a relatively smooth curve with gradual deceleration after the first six months
Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
Ozempic/Wegovy/Mounjaro/ Zepbound-Weight Loss Medications Biggest Side Effect-Reflux
Journal reference: Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024
That continuity of care creates a safer, more comfortable experience and leads to better outcomes